Sheba Medical Center

This study tests whether a powder made from a special alga can improve vision in 30 teenagers with retinitis pigmentosa, a genetic eye disease that causes vision loss. Participants will take the alga extract daily for a year while doctors measure changes in their eye function. Th…

This study compares a shortened 4-infusion course of the drug Teprotumumab (Tepezza) to the standard 8-infusion course in people with active thyroid eye disease. It aims to see if those who respond well early can safely stop treatment sooner. About 40 participants who show early …

This study tests a new treatment called SHB-02-CD19 for people with certain blood cancers (B-cell malignancies) that have come back or not responded to standard therapy. The treatment uses the patient's own immune cells, modified to recognize and attack cancer cells. The goal is …

This study tests whether a natural supplement made from algae can improve vision in adults with Retinitis Pigmentosa, an inherited eye disease that causes gradual vision loss. Forty-one participants will take either the supplement or a placebo for 3 months, then switch after a 6-…

This study tests a non-invasive wireless patch that monitors facial nerve activity during parotid or facial surgery, aiming to see if it works as well as the standard needle-based method. Twenty adults will have both monitoring methods used during their surgery, and researchers w…

This study looks at whether S-ketamine changes the function of mitochondria (the energy centers of cells) in people with treatment-resistant depression. Researchers will take blood samples from 30 adults before, shortly after, and six weeks after treatment to see if these changes…